Navidea Awarded $1.7 Million Fast Track NIH SBIR Grant for Evaluation of Manocept™ in Rheumatoid ArthritisBusiness Wire via Yahoo! FinanceJul 29 04:30 AM
Navidea announces the receipt of an initial notice of award for a Fast Track Small Business Innovation Research grant providing for up to $1.7 million from the National Institutes of Health’s National Institute of Arthritis and Musculoskeletal and Skin Diseases , to fund preclinical animal studies and a Phase 1/2 human clinical study examining the ability of Tc 99m-tilmanocept, a Manocept™ ...
- Business Wire via Yahoo! FinanceJul 06 05:30 AM
Orbital ATK , a global leader in aerospace and defense technologies, announced today that it was chosen by the U.S. Small Business Administration as one of the 2015 Tibbetts award winners for the 2015 Small Business Innovative Research Award.
Targazyme Inc. Receives National Cancer Institute SBIR Award for Phase 2 Clinical Study of TZ101-Treated Regulatory T ...Marketwired via Yahoo! FinanceJul 27 12:48 PM
Targazyme, Inc., a clinical-stage biopharmaceutical company developing novel enzyme technologies and products to improve efficacy outcomes for stem cell transplantation, immunotherapy, gene therapy and ...
Metactive Awarded Phase I SBIR Grant from the National Heart, Lung, and Blood Institute of the National Institutes of ...Business Wire via Yahoo! FinanceJul 21 07:13 AM
Metactive Medical Inc. , an early-stage company focused on developing embolization devices for the treatment of peripheral vascular and neurovascular diseases, announced today that it has received a $224,000 Phase I SBIR grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health .
Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 ...PR Newswire via Yahoo! FinanceJul 30 04:30 AM
WARRINGTON, Pa., July 30, 2015 /PRNewswire/ -- Discovery Laboratories, Inc. (DSCO) today announced that it has received the second $1.0M tranche under a previously awarded Phase II Small Business Innovation Research ( SBIR) grant valued at up to $3.0 million to support continued development of the company's aerosolized KL4 surfactant as a potential medical countermeasure to mitigate acute and ...
- PR Newswire via Yahoo! FinanceJul 21 05:30 AM
ROCHESTER, N.Y., July 21, 2015 /PRNewswire/ -- The U.S. Department of Energy (DOE) issued topics yesterday for the upcoming FY16 Phase I Release I Funding Opportunity Announcement (FOA). To align with this release, DOE's SBIR/STTR Phase 0 Assistance Program is now accepting applications from eligible small businesses. As the only federal Phase 0 program, this initiative is designed to increase ...
- Business Wire via Yahoo! FinanceJul 09 04:00 AM
Akoustis Technologies, Inc. , a manufacturer of innovative single crystal Bulk ONE™ RF filters for mobile wireless, announced today that it received a Small Business Innovation Research Phase 1B award from the National Science Foundation .
- Marketwired via Yahoo! FinanceJul 20 07:00 AM
Boston Micromachines Corporation, a leading provider of MEMS-based deformable mirror products for adaptive optics systems, announced today that it has begun working on a NASA contract to substantially ...
- PharmiWebJul 17 08:12 AM
MOUNTAIN VIEW, Calif., July 17, 2015 MOUNTAIN VIEW, Calif., July 17, 2015 /PRNewswire/ -- Cellecta, a U.S.-based functional genomics company, announces the receipt of Phase I SBIR grant funds from the National Institute of Health (NIH) to further its CRISPR-mediated genome-editing program.
Trophogen, Inc. Awarded $756,000 for Second Year of Phase 2 NIH/NCI Fast Track SBIR Grant for Development of Novel ...Business Wire via Yahoo! FinanceJul 07 12:26 PM
Trophogen, Inc., a U.S.-based emerging biotechnology company founded in 2001, today announced that it was awarded the second year of its Phase 2 Fast Track component of $756,000 for a Small Business Innovation Research Award from the National Cancer Institute of the National Institutes of Health to develop novel VEGF analogs for targeted imaging of undifferentiated thyroid cancer.